Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis

Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis

ObjectiveUse of benzodiazepines and Z-drugs (non-benzodiazepine sedative hypnotics) is controversial due to adverse health outcomes in the general population. However, little is known about their use in people with multiple sclerosis (MS). We estimated the incidence and prevalence of benzodiazepine...

Full description

Bibliographic Details
Main Authors: Ruth Ann Marrie, John D. Fisk, Randy Walld, James M. Bolton, Jitender Sareen, Scott B. Patten, Alexander Singer, Lisa M. Lix, Carol A. Hitchon, Renée El-Gabalawy, Alan Katz, James J. Marriott, Charles N. Bernstein, the CIHR Team in Defining the Burden Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Neurology
Subjects:
multiple sclerosis
benzodiazepines
Z-drugs
cohort
psychiatric comorbidity
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.874724/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.874724/full

Similar Items